(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Oncología > Terapia celular > DA - CIMA - Oncología - Terapia celular - Artículos de Revista >

Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth
Autor(es) : Aguirre, X. (Xavier)
Jimenez-Velasco, A. (A.)
San-Jose, E. (Edurne)
Garate, L. (Leire)
Bandres, E. (Eva)
Cordeu, L. (Lucía)
Aparicio, O. (Óscar)
Saez, B. (Borja)
Navarro, G. (Germán)
Vilas, A. (Amaia)
Perez-Roger, I. (Ignacio)
Garcia-Foncillas, J. (Jesús)
Heiniger, A. (A.)
Calasanz-Abinzano, M.J. (Maria Jose)
Fortes, P. (Puri)
Roman-Gomez, J. (José)
Prosper, F. (Felipe)
Palabras clave : Materias Investigacion::Ciencias de la Salud::Oncología
Fecha incorporación: 2008
Editorial : American Association for Cancer Research
Versión del editor: http://dx.doi.org/doi:10.1158/1541-7786.MCR-08-0167
ISSN: 1541-7786
Cita: Agirre, X., Jiménez-Velasco, A., San Jose-Eneriz, E., Garate, L. et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res 2008; 6(12): 1830-1840
Resumen
MicroRNAs (miRNA) are small noncoding, single-stranded RNAs that inhibit gene expression at a posttranscriptional level, whose abnormal expression has been described in different tumors. The aim of our study was to identify miRNAs potentially implicated in chronic myeloid leukemia (CML). We detected an abnormal miRNA expression profile in mononuclear and CD34+ cells from patients with CML compared with healthy controls. Of 157 miRNAs tested, hsa-miR-10a, hsa-miR-150, and hsa-miR-151 were down-regulated, whereas hsa-miR-96 was up-regulated in CML cells. Down-regulation of hsa-miR-10a was not dependent on BCR-ABL1 activity and contributed to the increased cell growth of CML cells. We identified the upstream stimulatory factor 2 (USF2) as a potential target of hsa-miR-10a and showed that overexpression of USF2 also increases cell growth. The clinical relevance of these findings was shown in a group of 85 newly diagnosed patients with CML in which expression of hsa-miR-10a was down-regulated in 71% of the patients, whereas expression of USF2 was up-regulated in 60% of the CML patients, with overexpression of USF2 being significantly associated with decreased expression of hsa-miR-10a (P = 0.004). Our results indicate that down-regulation of hsa-miR-10a may increase USF2 and contribute to the increase in cell proliferation of CML implicating a miRNA in the abnormal behavior of CML.
Enlace permanente: http://hdl.handle.net/10171/17940
Aparece en las colecciones: DA - CIMA - Terapia génica y Hepatología - Vectores - Artículos de revista
DA - CIMA - Oncología - Síndromes mieloproliferativos - Artículos de Revista
DA - CIMA - Oncología - Terapia celular - Artículos de Revista
DA - CUN - Área de Terapia Celular - Artículos de revista
DA - Medicina - Hematología - Artículos de revista

Ficheros en este registro:
Fichero:  2008_MCR_Agirre_Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth.pdf
Descripción: 
Tamaño:  852,36 kB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.